Epac1 promotes melanoma metastasis via modification of heparan sulfate

Pigment Cell and Melanoma Research

Volumn 24, Issue 4, 2011, Pages 680-687

  Baljinnyam, Erdene ^a   Umemura, Masanari ^a   De Lorenzo, Mariana S ^a   Iwatsubo, Mizuka ^a   Chen, Suzie ^b   Goydos, James S ^c   Iwatsubo, Kousaku ^a,d  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epac; Heparan sulfate; Melanoma; Migration; N sulfation; NDST 1; Tissue microarray

Indexed keywords

ANTIPORTER; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CYCLIC AMP; HEPARAN SULFATE; N DEACETYLASE; N SULFOTRANSFERASE 1; TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SULFATION; TISSUE MICROARRAY;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; GENE DELETION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEPARITIN SULFATE; HUMANS; MELANOMA; MICE; NEOPLASM METASTASIS; SKIN NEOPLASMS; STAINING AND LABELING; SULFOTRANSFERASES;

MUS;

EID: 80051898733     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2011.00863.x     Document Type: Article

References (33)

1. Abramsson, A., Kurup, S., Busse, M. et al. (2007). Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev. 21, 316-331.
2. Aikawa, J.-I., and Esko, J.D. (1999). Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family. J. Biol. Chem. 274, 2690-2695.
3. Baljinnyam, E., Iwatsubo, K., Kurotani, R., Wang, X., Ulucan, C., Iwatsubo, M., Lagunoff, D., and Ishikawa, Y. (2009). Epac increases melanoma cell migration by a heparan sulfate-related mechanism. Am. J. Physiol. Cell Physiol. 297, C802-C813.
4. Baljinnyam, E., De Lorenzo, M.S., Xie, L.H., Iwatsubo, M., Chen, S., Goydos, J.S., Nowycky, M.C., and Iwatsubo, K. (2010). Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism. Cancer Res. 70, 5607-5617.
5. Berwick, M., and Wiggins, C. (2006). The current epidemiology of cutaneous malignant melanoma. Front. Biosci. 11, 1244-1254.
6. Bos, J.L. (2006). Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31, 680-686.
7. Chalkiadaki, G., Nikitovic, D., Berdiaki, A., Sifaki, M., Krasagakis, K., Katonis, P., Karamanos, N.K., and Tzanakakis, G.N. (2009). Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism. Int. J. Biochem. Cell Biol. 41, 1323-1331.
8. De Rooij, J., Zwartkruis, F.J.T., Verheijen, M.H.G., Cool, R.H., Nijman, S.M.B., Wittinghofer, A., and Bos, J.L. (1998). Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396, 474-477.
9. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., and Rees, D.C. (1996). Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120.
10. Furuhashi, M., Sjoblom, T., Abramsson, A. et al. (2004). Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res. 64, 2725-2733.
11. Gaggioli, C., and Sahai, E. (2007). Melanoma invasion - current knowledge and future directions. Pigment Cell Res. 20, 161-172.
12. Galante, L.L., and Schwarzbauer, J.E. (2007). Requirements for sulfate transport and the diastrophic dysplasia sulfate transporter in fibronectin matrix assembly. J. Cell Biol. 179, 999-1009.
13. Grandoch, M., Rose, A., Ter Braak, M., Jendrossek, V., Rubben, H., Fischer, J.W., Schmidt, M., and Weber, A.A. (2009). Epac inhibits migration and proliferation of human prostate carcinoma cells. Br. J. Cancer 101, 2038-2042.
14. Iwatsubo, K., Minamisawa, S., Tsunematsu, T., Nakagome, M., Toya, Y., Tomlinson, J.E., Umemura, S., Scarborough, R.M., Levy, D.E., and Ishikawa, Y. (2004). Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration. J. Biol. Chem. 279, 40938-40945.
15. Iwatsubo, K., Suzuki, S., Li, C. et al. (2007). Dopamine induces apoptosis in young, but not in neonatal, neurons via Ca (2+)-dependent signal. Am. J. Physiol. Cell Physiol. 293, C1498-C1508.
16. Kreuger, J., Prydz, K., Pettersson, R.F., Lindahl, U., and Salmivirta, M. (1999). Characterization of fibroblast growth factor 1 binding heparan sulfate domain. Glycobiology 9, 723-729.
17. Kreuger, J., Matsumoto, T., Vanwildemeersch, M., Sasaki, T., Timpl, R., Claesson-Welsh, L., Spillmann, D., and Lindahl, U. (2002). Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J. 21, 6303-6311.
18. Lissitzky, J.C., Parriaux, D., Ristorcelli, E., Verine, A., Lombardo, D., and Verrando, P. (2009). Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Cancer Res. 69, 802-809.
19. Maccarana, M., Casu, B., and Lindahl, U. (1993). Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 268, 23898-23905.
20. Nesbit, M., Nesbit, H.K., Bennett, J., Andl, T., Hsu, M.Y., Dejesus, E., Mcbrian, M., Gupta, A.R., Eck, S.L., and Herlyn, M. (1999). Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18, 6469-6476.
21. O'sullivan, G.M., Boswell, C.M., and Halliday, G.M. (2000). Langerhans cell migration is modulated by N-sulfated glucosamine moieties in heparin. Exp. Dermatol. 9, 25-33.
22. Pan, Y., Carbe, C., Powers, A., Zhang, E.E., Esko, J.D., Grobe, K., Feng, G.S., and Zhang, X. (2008). Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 135, 301-310.
23. Quilliam, L.A., Rebhun, J.F., and Castro, A.F. (2002). A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. Prog. Nucleic Acid Res. Mol. Biol. 71, 391-444.
24. Schlessinger, J., Plotnikov, A.N., Ibrahimi, O.A., Eliseenkova, A.V., Yeh, B.K., Yayon, A., Linhardt, R.J., and Mohammadi, M. (2000). Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743-750.
25. Sharma, B., Handler, M., Eichstetter, I., Whitelock, J.M., Nugent, M.A., and Iozzo, R.V. (1998). Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J. Clin. Invest. 102, 1599-1608.
26. Stenzel, D., Nye, E., Nisancioglu, M., Adams, R.H., Yamaguchi, Y., and Gerhardt, H. (2009). Peripheral mural cell recruitment requires cell-autonomous heparan sulfate. Blood 114, 915-924.
27. Thompson, S.M., Fernig, D.G., Jesudason, E.C., Losty, P.D., Van De Westerlo, E.M., Van Kuppevelt, T.H., and Turnbull, J.E. (2009). Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities. J. Biol. Chem. 284, 35621-35631.
28. Tiwari, S., Felekkis, K., Moon, E.Y., Flies, A., Sherr, D.H., and Lerner, A. (2004). Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood 103, 2661-2667.
29. Ugurel, S., Hildenbrand, R., Zimpfer, A. et al. (2005). Lack of clinical efficacy of imatinib in metastatic melanoma. Br. J. Cancer 92, 1398-1405.
30. Welch, D.R., Bisi, J.E., Miller, B.E., Conaway, D., Seftor, E.A., Yohem, K.H., Gilmore, L.B., Seftor, R.E., Nakajima, M., and Hendrix, M.J. (1991). Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer 47, 227-237.
31. Westphal, J.R., Van't Hullenaar, R., Peek, R., Willems, R.W., Crickard, K., Crickard, U., Askaa, J., Clemmensen, I., Ruiter, D.J., and De Waal, R.M. (2000). Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Int. J. Cancer 86, 768-776.
32. Yohem, K.H., Clothier, J.L., Montague, S.L., Geary, R.J., Winters, A.L. 3rd, Hendrix, M.J., and Welch, D.R. (1991). Inhibition of tumor cell invasion by verapamil. Pigment Cell Res. 4, 225-233.
33. Zhang, J., Park, S.I., Artime, M.C., Summy, J.M., Shah, A.N., Bomser, J.A., Dorfleutner, A., Flynn, D.C., and Gallick, G.E. (2007). AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. J. Clin. Invest. 117, 2962-2973.